Know Labs, Inc. (OTCQB: KNWN) formerly known as Visualant, is a premier non-invasive medical diagnostics company that is leveraging its proprietary electromagnetic energy technology platforms, namely ChromaID and Bio-RFID technologies, to capture the unique molecular signature of any substance or material. The Company shared preliminary study...
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company, is developing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, an approach that has the potential to address the unmet needs in cardiovascular, metabolic and fatty liver diseases. The Company’s research is...
Replimune group, Inc. (NASDAQ: REPL) is leveraging the power of its proprietary Immulytic platform to create a leading-edge oncolytic immunotherapy program that can generate a patient-specific local as well as systemic immune response. The therapies not only fight against the current cancer but also eliminate...
Infinity Pharmaceuticals (NASDAQ: INFI) novel approach is based on Targeting Immune Suppressive Macrophages by selectively inhibiting PI3K-Gamma. The Company’s lead candidate eganelisib, is a first-in-class, oral, once-daily selective inhibitor of phosphoinositide-3-kinase gamma (PI3K-gamma), that has the potential to transform the immuno-oncology space. IPI-549 has demonstrated...
There is a lot of buzz around Acer Therapeutics (NASDAQ: ACER) resulting in the stock zooming skywards. The sudden interest in the company is based on rumors that the Company is likely to be acquired by Relief Therapeutics (OTCQB: RLFTF), a biopharmaceutical company whose lead...
iCAD, Inc. (NASDAQ: ICAD), a premier medical technology Company providing cutting-edge cancer detection and therapy solution, presented new research supporting ProFound AI platform, an FDA-cleared, CE marked world-class AI powered breast health solution that is revolutionizing screening and detection of breast cancers. The Company also...
Aveo Pharmaceuticals, Inc. (NASDAQ: AVEO) was one of our stock picks this week based on its promising pipeline and an impending FDA approval for FOTIVDA® (tivozanib). The Company has scored a big win with its approval, which not only validates its unique approach but also...
Misonix, Inc. (NASDAQ: MSON) is building a highly differentiated surgical ultrasonic technology portfolio, to address and improve patient outcomes in neurosurgery, spine surgery, general surgery, orthopedic surgery, wound debridement, and craniomaxillofacial surgery. A world-class specialist in Ultrasonic technology, the Company’s products and services find their...
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to fruition. While Vaccine development and therapeutics to combat the COVID-19 pandemic are at the forefront of development activities in the biotech sector,...
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a specialty pharmaceutical that seeks to address the unmet needs of patients suffering from Chronic and debilitating conditions. BELBUCA® (buprenorphine) is a buccal film that provides long-acting pain relief, by leveraging its BioErodible MucoAdhesive (BEMA®) technology, and is...
